文献速递脑血管病

急性缺血性卒中患者重复血管内取栓:全国多中心数据库结果

Repeated Endovascular Thrombectomy in Patients With Acute Ischemic Stroke: Results From a Nationwide Multicenter Database.
PubMed 文献 · Stroke · 2019-12-23

该研究基于荷兰全国多中心注册数据库,回顾性分析2002至2017年间3928例接受血管内取栓的急性缺血性卒中患者,其中27例(0.7%)接受了重复血管内取栓(rEVT)。rEVT罕见,病因以心源性栓塞为主(67%),70%复发闭塞位于同侧;rEVT后90天44%患者功能独立(mRS 0-2),33%死亡,不良事件包括颅内出血7.4%、卒中进展3.7%和肺炎3.7%。rEVT看似安全,结局与单次治疗病例相似,但可能存在选择偏倚。

要点

  • 重复血管内取栓在取栓患者中罕见,发生率仅0.7%。
  • rEVT后90天44%患者达到功能独立(mRS 0-2),33%死亡。
  • rEVT不良事件率低,包括颅内出血7.4%、卒中进展3.7%、肺炎3.7%。

核心结论

  • 在大规模全国性队列中,急性缺血性卒中取栓后重复血管内取栓罕见(0.7%)。
  • rEVT病因以心源性栓塞为主,多数复发大血管闭塞位于同侧。
  • rEVT看似安全,结局与单次治疗病例相似,但可能存在选择偏倚。

研究设计与样本

  • 回顾性分析荷兰全国多中心注册数据库(MR CLEAN Pretrial、MR CLEAN Trial及MR CLEAN Registry)。
  • 纳入2002至2017年间接受血管内取栓的3928例急性缺血性卒中患者,筛选前循环rEVT病例。
  • 分析患者特征、手术数据及90天改良Rankin量表(mRS)功能结局。

主要发现

  • 3928例取栓患者中27例(0.7%)接受了rEVT。
  • 两次手术中位间隔78天(范围1-1122天),11/27例在30天内再次治疗。
  • 心源性栓塞是最常见病因(18例,67%),19例(70%)复发闭塞位于同侧。
  • rEVT后90天,44%患者达到功能独立(mRS 0-2),33%死亡。
  • 不良事件包括颅内出血2/27(7.4%)、卒中进展1/27(3.7%)、肺炎1/27(3.7%)。

关键数值与推荐

  • rEVT后90天功能独立(mRS 0-2)比例为44%。
  • rEVT后90天死亡比例为33%。
  • 不良事件发生率:颅内出血7.4%,卒中进展3.7%,肺炎3.7%。

临床怎么用

  • 对于取栓后复发大血管闭塞的患者,可考虑重复血管内取栓,但需认识到其罕见性及选择偏倚可能。
  • 心源性栓塞患者复发风险较高,且多位于同侧,应加强监测与二级预防。
  • rEVT的安全性及功能结局与单次治疗相似,但需个体化评估获益与风险。

局限性

  • 回顾性设计,可能存在选择偏倚。
  • rEVT病例数少(27例),结果需谨慎解读。
  • 未报告未接受rEVT的复发患者的结局对比。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background and Purpose- Patients with acute ischemic stroke treated with endovascular thrombectomy may be treated with repeat endovascular thrombectomy (rEVT) in case of recurrent large vessel occlusion. Data on safety and efficacy of these interventions is scarce. Our aim is to report on frequency, timing, and outcome of rEVT in a large nation-wide multicenter registry. Methods- In the Netherlands, all patients with endovascular thrombectomy have been registered since 2002 (MR CLEAN Pretrial registry, MR CLEAN Trial [Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands], and MR CLEAN Registry). We retrospectively reviewed these databases for anterior circulation rEVT cases. Patient characteristics, procedural data, and functional outcome (modified Rankin Scale at 90 days) were analyzed. Results- Of 3928 patients treated between 2002 and 2017, 27 (0.7%) underwent rEVT. Median time between first and second procedure was 78 (1-1122) days; 11/27 patients were re-treated within 30 days. Cardioembolism was the most common etiology (18 patients [67%]). In 19 patients (70%), recurrent occlusion occurred ipsilateral to previous occlusion. At 90 days after rEVT procedure, 44% of the patients had achieved functional independence (modified Rankin Scale score of 0-2), and 33% had died. Adverse events were 2/27 (7.4%) intracranial hemorrhage, 1/27 (3.7%) stroke progression, and 1/27 (3.7%) pneumonia. Conclusions- In this large nationwide cohort of patients with acute ischemic stroke treated with endovascular thrombectomy, rEVT was rare. Stroke cause was mainly cardio-embolic, and most recurrent large vessel occlusions in which rEVT was performed occurred ipsilateral. Although there probably is a selection bias on repeated treatment in case of recurrent large vessel occlusion, rEVT appears safe, with similar outcome as in single-treated cases.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Pirson FAV, van Oostenbrugge RJ, van Zwam WH, et al. Repeated Endovascular Thrombectomy in Patients With Acute Ischemic Stroke: Results From a Nationwide Multicenter Database. Stroke. 2019. PMID: 31865897. doi:10.1161/STROKEAHA.119.027525

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。